Psychiatry
Suicidality
0
Pipeline Programs↗
1
Active Trials↗
0
Companies Involved↗
Suicidality is an early-stage landscape with 0 programs across 0 companies.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
11
clinical trials
Completed4 · 36%
Terminated3 · 27%
Unknown status2 · 18%
Withdrawn1 · 9%
Active, not recruiting1 · 9%
Clinical Trials
Trial Activity
11 trials
Ketamine + Cognitive Training for Suicidality in the Medical Setting
Active, not recruiting·—·Phase 4·NCT04578938·200 enrolled
Esketamine vs ECT for Acute Suicidality
Completed·—·N/A·NCT06355180·340 enrolled
Ketamine + Cognitive Training for Suicidality in the Medical Setting: Pilot
Terminated·—·Phase 4·NCT04154150·16 enrolled
A Study of Nopan Treatment of Acute Suicidality
Unknown status·—·Phase 3·NCT01046851·60 enrolled
Identification of Genetic Markers and Predictors of Antidepressant-induced Suicidality in Youth Depression
Unknown status·—·N/A·NCT02428439·80 enrolled
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)